The Pharmaceutical Journal
Vol 280 No 7484 p10
5/12 January 2008

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Paclitaxel combination

Treating metastatic breast cancer with paclitaxel plus bevacizumab prolongs progression-free survival, but not overall survival, compared with paclitaxel alone, according to a New England Journal of Medicine study (2007;357:2666).